BR112014011898A2 - métodos e composições para o tratamento de diabetes e sintomas relacionados - Google Patents

métodos e composições para o tratamento de diabetes e sintomas relacionados

Info

Publication number
BR112014011898A2
BR112014011898A2 BR112014011898A BR112014011898A BR112014011898A2 BR 112014011898 A2 BR112014011898 A2 BR 112014011898A2 BR 112014011898 A BR112014011898 A BR 112014011898A BR 112014011898 A BR112014011898 A BR 112014011898A BR 112014011898 A2 BR112014011898 A2 BR 112014011898A2
Authority
BR
Brazil
Prior art keywords
diabetes
compositions
treatment
methods
related symptoms
Prior art date
Application number
BR112014011898A
Other languages
English (en)
Portuguese (pt)
Inventor
Niihara Yutaka
Original Assignee
Emmaus Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48470183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014011898(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emmaus Medical Inc filed Critical Emmaus Medical Inc
Publication of BR112014011898A2 publication Critical patent/BR112014011898A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
BR112014011898A 2011-11-21 2012-11-17 métodos e composições para o tratamento de diabetes e sintomas relacionados BR112014011898A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161629633P 2011-11-21 2011-11-21
PCT/US2012/000557 WO2013077893A1 (en) 2011-11-21 2012-11-17 Methods and compositions for the treatment of diabetes and related symptoms

Publications (1)

Publication Number Publication Date
BR112014011898A2 true BR112014011898A2 (pt) 2017-05-16

Family

ID=48470183

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014011898A BR112014011898A2 (pt) 2011-11-21 2012-11-17 métodos e composições para o tratamento de diabetes e sintomas relacionados

Country Status (10)

Country Link
US (2) US20130143968A1 (enExample)
EP (2) EP2782588B1 (enExample)
JP (4) JP6089042B2 (enExample)
CN (3) CN103945858A (enExample)
BR (1) BR112014011898A2 (enExample)
ES (1) ES2785094T3 (enExample)
HK (1) HK1257401A1 (enExample)
IN (1) IN2014KN01037A (enExample)
PH (2) PH12020550726B1 (enExample)
WO (1) WO2013077893A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
MA49906A (fr) 2017-08-14 2020-06-24 Axcella Health Inc Acides aminés à chaîne ramifiée pour le traitement d'une maladie du foie
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
CA2424645A1 (en) * 2001-06-27 2003-01-09 Probiodrug Ag New use of dipeptidyl peptidase iv inhibitors
SE0201713D0 (sv) * 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
TWI351278B (en) * 2002-03-01 2011-11-01 Nisshin Pharma Inc Agent for preventing and treating of liver disease
US20070025953A1 (en) * 2005-07-27 2007-02-01 Jones Michael R Co-therapy for diabetic conditions
CN101472579B (zh) * 2006-04-22 2013-07-03 霍利斯-伊登医药公司 药物和用途
EP2077110A4 (en) * 2006-09-29 2012-06-27 Ajinomoto Kk GLUTAMINE-CONTAINING COMPOSITION FOR INCREASING BLOOD FLOW
US20080221074A1 (en) * 2006-11-17 2008-09-11 Jaime Flores-Riveros Drug Screen and Treatment Method
EP2057905A1 (en) * 2007-11-12 2009-05-13 TIMA Foundation Composition for moderating Triglyceride and Cholesterol Levels
US8470885B2 (en) * 2009-01-12 2013-06-25 Biokier, Inc. Composition and method for treatment of diabetes
NL1036746C2 (nl) * 2009-03-20 2010-09-21 Glnp Holding B.V. Kit van onderdelen bevattende l-glutamine en egcg.
MX2012003459A (es) * 2009-09-23 2012-05-22 Biokier Inc Composicion y metodo para el tratamiento de la diabetes.

Also Published As

Publication number Publication date
ES2785094T3 (es) 2020-10-05
US20190192463A1 (en) 2019-06-27
JP2018199692A (ja) 2018-12-20
PH12014501052A1 (en) 2014-06-30
JP2014533689A (ja) 2014-12-15
PH12014501052B1 (en) 2020-10-09
WO2013077893A1 (en) 2013-05-30
JP6550160B2 (ja) 2019-07-24
CN103945858A (zh) 2014-07-23
JP2017052766A (ja) 2017-03-16
PH12020550726A1 (en) 2021-06-14
EP2782588B1 (en) 2020-04-15
JP6089042B2 (ja) 2017-03-01
JP2018115175A (ja) 2018-07-26
IN2014KN01037A (en) 2015-10-09
EP2782588A1 (en) 2014-10-01
EP2782588A4 (en) 2015-05-20
JP6389495B2 (ja) 2018-09-12
CN108478551A (zh) 2018-09-04
HK1257401A1 (zh) 2019-10-18
CN108354916A (zh) 2018-08-03
PH12020550726B1 (en) 2022-11-09
EP3437649A1 (en) 2019-02-06
US20130143968A1 (en) 2013-06-06

Similar Documents

Publication Publication Date Title
LTPA2020510I1 (lt) Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui
BR112013019732A2 (pt) composições e métodos para tratamento de doenças cardiovasculares
PT2523661T (pt) Inibidores de nkcc para o tratamento de autismo
PT2919796T (pt) Utilização de akkermansia para o tratamento de distúrbios metabólicos
IL229474A0 (en) Cannabinoids for use in the treatment of neuropatich pain
HUE043171T2 (hu) Neurodegeneratív betegségek kezelésére hasznos 1-arilkarbonil-4-oxi-piperidinvegyületek
CO6801724A2 (es) Composiciones y métodos para el tratamiento de la mielofibrosis
CO6960110A1 (es) Composición aditiva para fluidos de tratamiento de pozos
EP2675909A4 (en) GLUCOSYLSTEVIA COMPOSITION
EP2720561A4 (en) Stevia-COMPOSITION
EP2713762A4 (en) Stevia-COMPOSITION
BR112014000033A2 (pt) compostos para o tratamento de dependência química
IL228030B (en) Compounds for treating hyperuricemia and metabolic disorders associated with hyperuricemia
PT2768859T (pt) Antagonistas de il17c para o tratamento de desordens inflamatórias
BR112014004416A2 (pt) composições e métodos para o tratamento de doenças neurodegenerativas
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
PL2704734T3 (pl) Kompozycja użyteczna do leczenia zaburzeń metabolizmu lipidów
BR112014006291A2 (pt) composição e utilização da composição
IL284347A (en) Geranium oil and constituents thereof for treatment of neurodegenerative diseases
PL2718434T3 (pl) Kompozycje i sposoby leczenia choroby trzewnej
BR112014004414A2 (pt) composições e métodos para tratar doença neurodegenerativa
CO6801718A2 (es) Composición terapéutica para el tratamiento de glioblastoma
BR112012006437A2 (pt) composições e métodos para tratamento do diabetes e outros distúrbios
PT2812013T (pt) Formulação para o tratamento do sii
PL2632475T3 (pl) Kompozycje do leczenia wrzodów peryferyjnych o zróżnicowanym pochodzeniu

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2801 DE 10/09/2024.